Related Experiment Video
Updated: Jul 30, 2025
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Molecular characterization of sub-frontal recurrent medulloblastomas reveals potential clinical relevance
Zirong Chen1, Huaitao Yang2, Jiajia Wang3
1Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Background:
Single recurrence in the sub-frontal region after cerebellar medulloblastoma (MB) resection is rare and the underlying molecular characteristics have not been specifically addressed.
Methods:
We summarized two such cases in our center. All five samples were molecularly profiled for their genome and transcriptome signatures.
Results:
The recurrent tumors displayed genomic and transcriptomic divergence. Pathway analysis of recurrent tumors showed functional convergence in metabolism, cancer, neuroactive ligand-receptor interaction, and PI3K-AKT signaling pathways. Notably, the sub-frontal recurrent tumors had a much higher proportion (50-86%) of acquired driver mutations than that reported in other recurrent locations. The acquired putative driver genes in the sub-frontal recurrent tumors functionally enriched for chromatin remodeler-associated genes, such as KDM6B, SPEN, CHD4, and CHD7. Furthermore, the germline mutations of our cases showed a significant functional convergence in focal adhesion, cell adhesion molecules, and ECM-receptor interaction. Evolutionary analysis showed that the recurrence could be derived from a single primary tumor lineage or had an intermediate phylogenetic similarity to the matched primary one.
Conclusion:
Rare single sub-frontal recurrent MBs presented specific mutation signatures that might be related to the under-dose radiation. Particular attention should be paid to optimally covering the sub-frontal cribriform plate during postoperative radiotherapy targeting.
Insights
Single sub-frontal medulloblastoma recurrences are rare and exhibit unique molecular signatures. These findings highlight the need for precise radiotherapy targeting to improve patient outcomes.
Area of Science:
- Neuro-oncology
- Genomics
- Transcriptomics
Background:
- Single sub-frontal recurrences after cerebellar medulloblastoma (MB) resection are infrequent.
- The molecular characteristics of these rare recurrences remain largely unaddressed.
Purpose of the Study:
- To investigate the genomic and transcriptomic profiles of rare single sub-frontal medulloblastoma recurrences.
- To identify potential molecular drivers and therapeutic targets for these specific tumor types.
Main Methods:
- Molecular profiling of five patient samples, including genome and transcriptome sequencing.
- Pathway analysis to identify enriched biological processes.
- Evolutionary analysis to understand tumor lineage and recurrence patterns.
Main Results:
- Recurrent tumors showed genomic and transcriptomic divergence from primary tumors.
- Enriched pathways included metabolism, cancer signaling, neuroactive ligand-receptor interactions, and PI3K-AKT signaling.
- Sub-frontal recurrences exhibited a high proportion of acquired driver mutations, particularly in chromatin remodeler-associated genes (e.g., KDM6B, SPEN, CHD4, CHD7).
- Germline mutations converged on focal adhesion and cell adhesion pathways.
Conclusions:
- Rare single sub-frontal recurrent medulloblastomas possess distinct mutation signatures, potentially linked to radiotherapy under-dosing.
- Optimal radiotherapy requires careful coverage of the sub-frontal cribriform plate.
